Abbott Laboratories
ABT | NYSE
$108.91
+$2.71 (+2.55%)
Nov 2, 2026, 12:52 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 5.43B | 6.28B | 6.52B | 13.98B | 13.98B | 13.5B | 13.4B | 5.77B | 5.56B | 5.63B | 5.72B | 5.16B | 5.16B | 5.8B | 6.93B | 7.89B | 8.55B | 7.73B | 7.07B | 7.24B | 6.38B | 5.72B |
Depreciation & Amortization | 3.33B | 3.09B | 3.12B | 3.13B | 3.14B | 3.17B | 3.22B | 3.22B | 3.25B | 3.24B | 3.24B | 3.24B | 3.23B | 3.25B | 3.27B | 3.34B | 3.38B | 3.43B | 3.54B | 3.52B | 3.48B | 3.43B |
Stock-Based Compensation | 718M | 692M | 664M | 662M | 659M | 658M | 673M | 676M | 676M | 667M | 644M | 645M | 651M | 661M | 685M | 676M | 667M | 657M | 640M | 632M | 618M | 601M |
Other Working Capital | 1.34B | -330M | -346M | -8.93B | -9.15B | -8.9B | -8.47B | -1.89B | -2.07B | -2.73B | -3.8B | -1.95B | -1.7B | -951M | -80M | -1.26B | -1.37B | -1.56B | 8B | 7.98B | 15.15B | 21.51B |
Other Non-Cash Items | -217M | 138M | 65M | 1.11B | 1.09B | 1.23B | 482M | 1.41B | 1.25B | 454M | 1.2B | -582M | -332M | 328M | 328M | 266M | 195M | 195M | 189M | 377M | 624M | 788M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 653M | -732M | -803M | -9.76B | -9.83B | -9.61B | -9.22B | -2.35B | -2.83B | -2.85B | -3.55B | -1.91B | -1.26B | -1.38B | -1.63B | -1.85B | -2.55B | -2.04B | -905M | -510M | -471M | -723M |
Operating Cash Flow | 9.91B | 9.46B | 9.57B | 9.12B | 9.04B | 8.95B | 8.56B | 8.73B | 7.9B | 7.14B | 7.26B | 6.55B | 7.45B | 8.66B | 9.58B | 10.32B | 10.24B | 9.96B | 10.53B | 11.26B | 10.63B | 9.82B |
Capital Expenditures | -1.19B | -2.09B | -2.17B | -2.2B | -2.26B | -2.29B | -2.21B | -2.24B | -2.25B | -2.22B | -2.2B | -2.06B | -1.96B | -1.84B | -1.78B | -1.78B | -1.78B | -1.81B | -1.89B | -1.95B | -1.99B | -2.21B |
Cash Acquisitions | -20.07B | -19.9B | -105M | -55M | n/a | 1M | 1M | 1M | -50M | -837M | -837M | -837M | -786M | 48M | 48M | -86M | -172M | -172M | -187M | -111M | -25M | -57M |
Purchase of Investments | -284M | -328M | -167M | -169M | -213M | -141M | -169M | -114M | -152M | -101M | -159M | -227M | -192M | -230M | -185M | -176M | -200M | -227M | -200M | -110M | -83M | -97M |
Sales Maturities Of Investments | 3M | -5M | 3M | 65M | -21M | 36M | 28M | 52M | 130M | 788M | 788M | 745M | 707M | n/a | n/a | 77M | -4M | 77M | 77M | 10M | 91M | 10M |
Other Investing Acitivies | 62M | 46M | 18M | -14M | -16M | 14M | 9M | 7M | -18M | -726M | -723M | -565M | -556M | 176M | 174M | 187M | 205M | 185M | 187M | 93M | 113M | 114M |
Investing Cash Flow | -22.37B | -22.28B | -2.42B | -2.38B | -2.51B | -2.38B | -2.34B | -2.3B | -2.34B | -3.1B | -3.13B | -2.94B | -2.79B | -1.84B | -1.74B | -1.78B | -1.95B | -1.95B | -2.01B | -2.07B | -1.89B | -2.24B |
Debt Repayment | 16.44B | 17.9B | -1.61B | -2.16B | -1.62B | -1.45B | -537M | -863M | -2.41B | -2.56B | -2.48B | -1.53B | 4M | 2M | -699M | -905M | -996M | -1.01B | -248M | -53M | -1.34B | -78M |
Common Stock Repurchased | -1.83B | -793M | -893M | -906M | -1.35B | -1.35B | -1.3B | -1.24B | -490M | -913M | -1.23B | -1.65B | -2.45B | -2.03B | -3.8B | -4.08B | -3.87B | -4.33B | -2.3B | -1.49B | -909M | -442M |
Dividend Paid | -4.26B | -4.19B | -4.12B | -4.04B | -3.97B | -3.91B | -3.84B | -3.77B | -3.69B | -3.62B | -3.56B | -3.49B | -3.43B | -3.37B | -3.31B | -3.28B | -3.26B | -3.23B | -3.2B | -3.05B | -2.88B | -2.72B |
Other Financial Acitivies | 100M | -82M | -82M | -57M | 35M | 130M | 264M | 273M | 237M | 239M | 167M | 174M | 175M | 170M | 167M | 208M | 221M | 228M | 255M | 189M | 202M | 231M |
Financial Cash Flow | 10.64B | 13.06B | -6.31B | -6.77B | -6.59B | -6.28B | -5.4B | -5.6B | -6.36B | -6.86B | -7.09B | -6.5B | -5.7B | -5.22B | -7.64B | -8.07B | -7.9B | -8.35B | -5.49B | -4.4B | -4.93B | -3.01B |
Net Cash Flow | -1.85B | 271M | 906M | -47M | -36M | 248M | 720M | 849M | -848M | -2.88B | -2.99B | -2.89B | -1.1B | 1.49B | 83M | 292M | 279M | -379M | 2.96B | 4.82B | 3.9B | 4.68B |
Free Cash Flow | 8.72B | 7.38B | 7.4B | 6.92B | 6.78B | 6.66B | 6.35B | 6.49B | 5.65B | 4.92B | 5.06B | 4.49B | 5.49B | 6.82B | 7.8B | 8.54B | 8.47B | 8.15B | 8.65B | 9.31B | 8.64B | 7.61B |
Adj. Free Cash Flow | 8B | 6.69B | 6.73B | 6.26B | 6.12B | 6B | 5.68B | 5.81B | 4.98B | 4.26B | 4.42B | 3.85B | 4.84B | 6.16B | 7.12B | 7.87B | 7.8B | 7.5B | 8.01B | 8.68B | 8.03B | 7.01B |
Maintenance CapEx | -1.65B | -1.55B | -1.53B | -1.5B | -1.63B | -1.76B | -1.72B | -1.91B | -2.04B | -2.12B | -2.16B | -2.06B | -1.96B | -1.57B | -1.19B | -985.99M | -518.99M | -408.97M | -408.97M | -16.2M | -296.45M | -938.45M |
Growth CapEx | 469.11M | -535.28M | -641.58M | -703.89M | -635.51M | -534.26M | -485.14M | -331.34M | -201.68M | -96.54M | -39.36M | n/a | n/a | -268.97M | -589.97M | -795.01M | -1.26B | -1.4B | -1.48B | -1.93B | -1.69B | -1.28B |
Owner Earnings | 8.25B | 7.91B | 8.04B | 7.62B | 7.41B | 7.19B | 6.84B | 6.82B | 5.86B | 5.02B | 5.1B | 4.49B | 5.49B | 7.09B | 8.39B | 9.34B | 9.72B | 9.55B | 10.12B | 11.25B | 10.33B | 8.88B |
Add to Watchlist
Select watchlists to add or remove ABT